Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOALPOST: BP Treatment Goals in Gestational Hypertension and Preeclampsia
NCT07746271Phase 3Not yet recruiting
- Sponsor
- George Washington University Biostatistics Center
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of labetalol, nifedipine GITS in gestational hypertension (GH), preeclampsia, sponsored by George Washington University Biostatistics Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
labetalolnifedipine GITS
03
Conditions
gestational hypertension (GH)preeclampsia
Beyond the preview
Go deeper on NCT07746271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746271.